ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement

Faroux, Laurent; Lhermusier, Thibault; Vincent, Flavien; Nombela‐Franco, Luis; Tchétché, Didier; Barbanti, Marco; Abdel‐Wahab, Mohamed; Windecker, Stephan; Auffret, Vincent; Campanha-Borges, Diego Carter; Fischer, Quentin; Muñoz-García, Érika; Trillo-Nouche, Ramiro; Jørgensen, Troels Højsgaard; Serra, Viçens; Toggweiler, Stefan; Tarantini, Giuseppe; Saia, Francesco; Durand, Éric; Donaint, Pierre; Gutiérrez‐Ibañes, Enrique; Wijeysundera, Harindra C.; Veiga, Gabriela; Patti, Giuseppe; D’Ascenzo, Fabrizio; Moreno, Raúl; Hengstenberg, Christian; Chamandi, Chekrallah; Asmarats, Lluís; Hernández‐Antolín, Rosana; Gómez‐Hospital, Joan Antoni; Córdoba-Soriano, Juan G.; Landes, Uri; Jiménez-Díaz, Víctor Alfonso; Cruz-González, Ignacio; Nejjari, Mohammed; Roubille, François; Belle, Éric Van; Armijo, Germán; Siddiqui, Saifullah; Costa, Giuliano; Elsaify, Sameh; Pilgrim, Thomas; Breton, Hervé; Ureña, Marina; Muñoz-García, Antonio J.; Søndergaard, Lars; Bach-Oller, Montserrat; Fraccaro, Chiara; Eltchaninoff, Hélène; Metz, Damien; Tamargo, María; Fradejas-Sastre, Víctor; Rognoni, Andrea; Bruno, Francesco; Goliasch, Georg; Santaló-Corcoy, Marcelo; Jiménez-Mazuecos, Jesús; Webb, John G.; Muntané‐Carol, Guillem; Paradis, Jean-Michal; Mangieri, Antonio; Ribeiro, Henrique Barbosa; Campelo‐Parada, Francisco; Rodés‐Cabau, Josep

doi:10.1016/j.jacc.2021.03.014

Cited by 43 publications

(13 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Assessing the feasibility of coronary access and PCI is increasingly relevant as TAVI expands toward younger and lower-risk patients who have an increased life-time risk for repeat invasive angiography due to progression of CAD ( 9 – 12 ). Studies using pre or post-procedural CT to virtually assess coronary access have suggested that challenging or un-feasible cannulation may occur following 9–35% TAVR ( 16 – 18 ), 27–78% of TAVI-in-TAVI ( 19 , 20 , 25 ) and 58% of ViV-TAVI ( 22 ) procedures.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Coronary access following ACURATE neo implantation for transcatheter aortic valve-in-valve implantation: Ex vivo analysis in patient-specific anatomies

Khokhar

Ponticelli

Złahoda-Huzior

et al. 2022

Front. Cardiovasc. Med.

Self Cite

View full text Add to dashboard Cite

BackgroundCoronary access after transcatheter aortic valve implantation (TAVI) with supra-annular self-expandable valves may be challenging or un-feasible. There is little data concerning coronary access following transcatheter aortic valve-in-valve implantation (ViV-TAVI) for degenerated surgical bioprosthesis.AimsTo evaluate the feasibility and challenge of coronary access after ViV-TAVI with the supra-annular self-expandable ACURATE neo valve.Materials and methodsSixteen patients underwent ViV-TAVI with the ACURATE neo valve. Post-procedural computed tomography (CT) was used to create 3D-printed life-sized patient-specific models for bench-testing of coronary cannulation. Primary endpoint was feasibility of diagnostic angiography and PCI. Secondary endpoints included incidence of challenging cannulation for both diagnostic catheters (DC) and guiding catheters (GC). The association between challenging cannulations with aortic and transcatheter/surgical valve geometry was evaluated using pre and post-procedural CT scans.ResultsDiagnostic angiography and PCI were feasible for 97 and 95% of models respectively. All non-feasible procedures occurred in ostia that underwent prophylactic “chimney” stenting. DC cannulation was challenging in 17% of models and was associated with a narrower SoV width (30 vs. 35 mm, p < 0.01), STJ width (28 vs. 32 mm, p < 0.05) and shorter STJ height (15 vs. 17 mm, p < 0.05). GC cannulation was challenging in 23% of models and was associated with narrower STJ width (28 vs. 32 mm, p < 0.05), smaller transcatheter-to-coronary distance (5 vs. 9.2 mm, p < 0.05) and a worse coronary-commissural overlap angle (14.3° vs. 25.6o, p < 0.01). Advanced techniques to achieve GC cannulation were required in 22/64 (34%) of cases.ConclusionIn this exploratory bench analysis, diagnostic angiography and PCI was feasible in almost all cases following ViV-TAVI with the ACURATE neo valve. Prophylactic coronary stenting, higher implantation, narrower aortic sinus dimensions and commissural misalignment were associated with an increased challenge of coronary cannulation.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Coronary access following TAVI can be challenging and if un-feasible is associated with adverse outcomes (11)(12)(13). Prior studies have identified various anatomical, procedural and device-related factors, which can influence the challenge of coronary access following TAVI and TAVI-in-TAVI procedures (14-21).…”

Section: Introductionmentioning

confidence: 99%

Coronary access following ACURATE neo implantation for transcatheter aortic valve-in-valve implantation: Ex vivo analysis in patient-specific anatomies

Khokhar

Ponticelli

Złahoda-Huzior

et al. 2022

Front. Cardiovasc. Med.

Self Cite

View full text Add to dashboard Cite

show abstract

“…TAVR valves have a valve stent frame which may impair coronary access, especially when it comes to self-expandable valve systems with a taller stent frame and a supra-annular valve leaflet insertion [ 42 , 43 , 44 , 45 ]. As such, coronary access in ST-elevation myocardial infarction in patients with TAVR took longer compared to non-TAVR patients, and up to 4.2% of patients could not undergo coronary revascularization because of coronary ostia cannulation failure [ 46 ]. In the RE-ACCESS study ( Reobtain Coronary Ostia Cannulation Beyond Transcatheter Aortic Valve Stent ), 7.7% of unsuccessful coronary canulations were observed after TAVR, mainly in the presence of self-expanding Evolut valves [ 47 ].…”

Section: Where Are We Going?mentioning

confidence: 99%

Evolving Indications of Transcatheter Aortic Valve Replacement—Where Are We Now, and Where Are We Going

Mesnier

Panagides

Nuche

et al. 2022

JCM

Self Cite

View full text Add to dashboard Cite

Indications for transcatheter aortic valve replacement (TAVR) have steadily increased over the last decade since the first trials including inoperable or very high risk patients. Thus, TAVR is now the most common treatment of aortic valve stenosis in elderly patients (vs. surgical aortic valve replacement -SAVR-). In this review, we summarize the current indications of TAVR and explore future directions in which TAVR indications can expand.

show abstract

“…According to the current studies, the best approach is to customize revascularization timing considering clinical characteristics, type of transcatheter aortic valve chosen, and complexity of CAD. A recent multicenter registry found that unplanned PCI after TAVR is rare and its incidence declines over time after TAVR [65] . Moreover, in this study [66] , the main indication to PCI was acute coronary syndrome in the first two years after TAVR.…”

Section: The Optimal Timing Of Revascularizationmentioning

confidence: 99%

“…Moreover, in this study [66] , the main indication to PCI was acute coronary syndrome in the first two years after TAVR. Multicenter registries [65][66][67] showed that coronary angiography and PCI in TAVI patients affected by acute coronary syndrome is usually successful but coronary ostia cannulation failure was associated with poorer outcomes. Although a difficult access to the coronaries after TAVR is a great concern, it may be even more difficult to engage the coronary ostia after TAVR-in-TAVR.…”

Section: The Optimal Timing Of Revascularizationmentioning

confidence: 99%

Management of concomitant coronary artery disease and aortic valve stenosis in the era of transcatheter aortic valve treatment

Aurigemma¹,

Romagnoli²,

Bianchini³

et al. 2022

MIS

View full text Add to dashboard Cite

Severe calcific aortic stenosis (AS) and coronary artery disease (CAD) have common risk factors and are frequently encountered in the same patient in clinical practice. CAD has been reported in ≥ 50% of AS patients undergoing both surgical treatment and transcatheter aortic valve implantation (TAVI). In the last two decades, TAVI has been established as a less invasive alternative to surgery. Recently, more and more young and low surgical risk patients undergo TAVI. Despite the high prevalence of CAD in patients treated with TAVI, the management strategy of concomitant CAD in these patients remains an area of considerable uncertainty. This review provides an updated overview of the current knowledge about this topic and offers points for reflection about the best approach to use.

show abstract

ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement

Cited by 43 publications

References 22 publications

Coronary access following ACURATE neo implantation for transcatheter aortic valve-in-valve implantation: Ex vivo analysis in patient-specific anatomies

Coronary access following ACURATE neo implantation for transcatheter aortic valve-in-valve implantation: Ex vivo analysis in patient-specific anatomies

Evolving Indications of Transcatheter Aortic Valve Replacement—Where Are We Now, and Where Are We Going

Management of concomitant coronary artery disease and aortic valve stenosis in the era of transcatheter aortic valve treatment

Contact Info

Product

Resources

About